Candid Therapeutics, Inc, a clinical-stage biotechnology company focused on becoming the leader in advancing T-cell engagers for autoimmune and inflammatory diseases, announced an agreement...
Vir Biotechnology, Inc, announced that it has entered into an exclusive worldwide license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and...
Ipsen and Marengo Therapeutics Inc, a clinical-stage biotech company, announced the expansion of their ongoing oncology research partnership, to include TriSTAR, Marengo’s next-generation, precision...
